Viable But Not Culturable Bacteria Induced by Manuka Honey Compared to Conventional Antibiotics

Faculty Mentor

Andrea R Castillo

Presentation Type

Poster

Start Date

May 2025

End Date

May 2025

Location

PUB NCR

Primary Discipline of Presentation

Biology

Abstract

Development of novel antimicrobials is critical to treat the large number of recurring infections due to antibiotic resistant bacteria. Bacteria can develop antibiotic resistance by entry into the metabolically inactive Viable But Not Culturable state (VBNC), where the bacteria are alive but not culturable on standard growth media. This state is triggered by environmental stressors including antibiotic exposure. Since most antibiotics target metabolic processes, metabolically inactive bacteria will be resistant to their effects. A promising antimicrobial, Manuka Honey (MH), is being investigated due to its broad-spectrum antimicrobial activity and recalcitrance to resistance. We hypothesize that the lack of resistance to MH may occur from the induction of fewer VBNCs. To test this hypothesis, we will compare VBNCs induced by treatment of the wound causing bacterium Escherichia coli with the minimum inhibitory concentration (MIC) of MH and the conventional antibiotic, ampicillin. We will first determine the MIC, the lowest concentration required to inhibit bacterial growth, for MH and ampicillin against E. coli. VBNCs will be calculated in these treated E. coli cultures as the number of viable cells, determined using live/dead staining and microscopy, minus the number of culturable cells, determined using a viable plate count. By comparing the induction of VBNCs by MH and ampicillin, this study may suggest a mechanism for the low antibiotic resistance to MH and support its widespread use as a topical antimicrobial over conventional antibiotics.

This document is currently not available here.

Share

COinS
 
May 7th, 9:00 AM May 7th, 11:00 AM

Viable But Not Culturable Bacteria Induced by Manuka Honey Compared to Conventional Antibiotics

PUB NCR

Development of novel antimicrobials is critical to treat the large number of recurring infections due to antibiotic resistant bacteria. Bacteria can develop antibiotic resistance by entry into the metabolically inactive Viable But Not Culturable state (VBNC), where the bacteria are alive but not culturable on standard growth media. This state is triggered by environmental stressors including antibiotic exposure. Since most antibiotics target metabolic processes, metabolically inactive bacteria will be resistant to their effects. A promising antimicrobial, Manuka Honey (MH), is being investigated due to its broad-spectrum antimicrobial activity and recalcitrance to resistance. We hypothesize that the lack of resistance to MH may occur from the induction of fewer VBNCs. To test this hypothesis, we will compare VBNCs induced by treatment of the wound causing bacterium Escherichia coli with the minimum inhibitory concentration (MIC) of MH and the conventional antibiotic, ampicillin. We will first determine the MIC, the lowest concentration required to inhibit bacterial growth, for MH and ampicillin against E. coli. VBNCs will be calculated in these treated E. coli cultures as the number of viable cells, determined using live/dead staining and microscopy, minus the number of culturable cells, determined using a viable plate count. By comparing the induction of VBNCs by MH and ampicillin, this study may suggest a mechanism for the low antibiotic resistance to MH and support its widespread use as a topical antimicrobial over conventional antibiotics.